Track record of delivering clinical assets through collaborative partnerships

Partnered Discovery

Using our proprietary platform we discover therapeutic antibodies that meet the highest standards of quality and developability. Isogenica has the in-house capability and expertise to efficiently undertake and manage all discovery & development activities from programme start to development.

Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline including two clinical assets and eight partnered pre-clinical and discovery programs.

Isogenica works with partners through collaborative research and commercial licenses to further develop proprietary LlamdA® VHH or to discover novel LlamdA® VHH as direct therapeutics and targeting agents.

Our experienced team learned their craft at Ablynx, Bicycle Therapeutics, Roche and other leading biopharma.